Delivery Order SPE2DB22D3501-SPE2DB25FUD48

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,970.07 firm fixed-price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,031.49 firm fixed-price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 22, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,464.59 firm fixed-price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,076.25 firm fixed-price delivery order is for the supply of CONCERTA ER 18 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,436.42 firm fixed-price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,954.97 firm-fixed-price delivery order contract is for the supply of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of May 10, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,127.62 firm-fixed-price delivery order contract, which has a completion date of March 7, 2025, is for the provision of 36 mg Concerta ER tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,171.76 firm fixed-price delivery order is for the supply of CONCERTA ER 27 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,235.50 firm fixed-price delivery order is for the supply of 4,566,704,094 units of CONCERTA ER 36 MG TABLET 100S, a specialty medication. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,329.43 firm fixed-price delivery order is for CONCERTA ER 36 MG TABLET 100S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUD48
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,023.79 firm fixed-price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S, a prescription medication.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. The award has an ultimate completion date of January 15, 2025.

Generated 4/16/25, 6:11 PM